lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262), 1mg*5

lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262), 1mg*5

Conatumumab (Anti-TNFRSF10B / TRAILR2 / CD262), 1mg

Conatumumab (Anti-TNFRSF10B / TRAILR2 / CD262), 1mg

lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262), 1mg*25

15.481,90 RON
SKU
SKM_A2330_1mg*25

Lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. MW : 145.5 KD.

Mai multe informatii
Price 13.010,00 RON (preturile sunt fara TVA)
Description

Lexatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. MW : 145.5 KD.